A model to estimate the risk of breast cancer-related lymphedema: Combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 86, Issue 3, 2013, Pages 498-503

  Kim, Myungsoo ^a   Kim, Seok Won ^a   Lee, Sung Uk ^a   Lee, Nam Kwon ^a   Jung, So Youn ^a   Kim, Tae Hyun ^a   Lee, Eun Sook ^a   Kang, Han Sung ^a   Shin, Kyung Hwan ^a  

^a National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CHEMOTHERAPY; DISEASES; DISSECTION; PATIENT TREATMENT; RADIOTHERAPY; RANGE FINDING; RISK ASSESSMENT; RISKS; SURGERY;

ADJUVANT CHEMOTHERAPY; AXILLARY LYMPH NODES; BREAST CANCER-RELATED LYMPHEDEMA; CUMULATIVE INCIDENCE; METHODS AND MATERIALS; RELATED FACTORS; SIMPLE MODELING; SUPRACLAVICULAR;

RISK PERCEPTION;

AROMATASE INHIBITOR; TAMOXIFEN; TRASTUZUMAB; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADULT; AGED; ARM EDEMA; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER MODEL; CANCER RADIOTHERAPY; CANCER RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LYMPH NODE DISSECTION; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PARTIAL MASTECTOMY; PATIENT ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIOTHERAPY UNIT; RETROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AXILLA; BREAST TUMOR; EPIDEMIOLOGY; MASTECTOMY; METHODOLOGY; RADIATION DOSE FRACTIONATION; RADIOTHERAPY; SEGMENTAL MASTECTOMY; TIME; UTILIZATION REVIEW;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; AXILLA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DOSE FRACTIONATION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC IRRADIATION; LYMPHEDEMA; MASTECTOMY, MODIFIED RADICAL; MASTECTOMY, SEGMENTAL; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RISK FACTORS; TIME FACTORS;

MLCS; MLOWN;

EID: 84880613501     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.02.018     Document Type: Article

References (17)

1. Gartner R, Jensen MB, Kronborg L, et al. Self-reported armlymphedema and functional impairment after breast cancer treatmentea nationwide study of prevalence and associated factors. Breast 2010;19:506-515.
2. Coen JJ, Taghian AG, Kachnic LA, et al. Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys 2003;55:1209-1215.
3. Soran A, D'Angelo G, Begovic M, et al. Breast cancer-related lymphedemadWhat are the significant predictors and how they affect the severity of lymphedema' Breast J 2006;12:536-543.
4. Purushotham AD, Bennett Britton TM, Klevesath MB, et al. Lymph node status and breast cancer-related lymphedema. Ann Surg 2007; 246:42-45.
5. Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 2006;13:491-500.
6. McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: Objective measurements. J Clin Oncol 2008;26:5213-5219.
7. Petrek JA, Senie RT, Peters M, et al. Lymphedema in a cohort of breast carcinomasurvivors 20 years after diagnosis. Cancer 2001;92:1368-1377.
8. Meeske KA, Sullivan-Halley J, Smith AW, et al. Risk factors for arm lymphedema following breast cancer diagnosis in black women and white women. Breast Cancer Res Treat 2009;113:383-391.
9. Norman SA, Localio AR, Potashnik SL, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol 2009;27:390-397.
10. Pezner RD, Patterson MP, Hill LR, et al. Arm lymphedema in patients treated conservatively for breast cancer: relationship to patient age and axillary node dissection technique. Int J Radiat Oncol Biol Phys 1986; 12:2079-2083.
11. Norman SA, Localio AR, Kallan MJ, et al. Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol Biomarkers Prev 2010;19:2734-2746.
12. Goldberg JI, Wiechmann LI, Riedel ER, et al. Morbidity of sentinel node biopsy in breast cancer: The relationship between the number of excised lymph nodes and lymphedema. Ann Surg Oncol 2010;17: 3278-3286.
13. McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: Patient perceptions and precautionary behaviors. J Clin Oncol 2008;26: 5220-5226.
14. Larson D, Weinstein M, Goldberg I, et al. Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 1986;12:1575-1582.
15. Sakorafas GH, Peros G, Cataliotti L, et al. Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 2006;15: 153-165.
16. Soran A, Wu WC, Dirican A, et al. Estimating the probability of lymphedema after breast cancer surgery. Am J Clin Oncol 2011;34: 506-510.
17. Bevilacqua JL, Kattan MW, Changhong Y, et al. Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer. Ann Surg Oncol 2012;19:2580-2589.